z-logo
Premium
B‐type natriuretic peptide levels predict event‐free survival in patients with implantable cardioverter defibrillators
Author(s) -
Christ Michael,
Sharkova Julia,
Bayrakcioglu Somer,
Herzum Ileana,
Mueller Christian,
Grimm Wolfram
Publication year - 2007
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1016/j.ejheart.2006.07.004
Subject(s) - medicine , natriuretic peptide , heart failure , cardiology , implantable cardioverter defibrillator
We examined whether B‐type natriuretic peptide (BNP) levels predict outcome in heart failure patients with implantable cardioverter defibrillators (ICD) using a combined endpoint of malignant tachyarrhythmias, death or heart transplantation. Methods and results: BNP levels were measured in 123 ICD patients with chronic heart failure (age: 63±12years, ejection fraction: 29±10%). After a median follow‐up of 25months, the combined endpoint was reached in 28 patients (first tachyarrhythmic event, n =16; death, n =11; heart transplantation, n =1). BNP levels were significantly lower in patients with event‐free survival compared to patients reaching the combined endpoint of this study (median: 140 vs. 373pg/ml; p <0.001). Multivariable Cox regression analysis revealed that BNP levels predict adverse outcome (RR 1.002 per pg/ml increment; 95% CI: 1.001–1.003; p <0.001) and use of beta‐blockers was associated with favourable outcome (RR 0.319; 95% CI 0.151–0.670; p =0.004). LV ejection fraction ( p =0.66) did not significantly predict event‐free survival in multivariable analysis. Conclusions: BNP plasma levels are useful markers to predict event‐free survival in ICD patients with heart failure. Of note, malignant tachyarrhythmias appear responsible for about 50% of fatal outcomes. Our findings suggest that determination of BNP plasma levels is more valuable than determining LV ejection fraction to anticipate event‐free survival in this population.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here